Total therapy study XV for newly diagnosed childhood acute lymphoblastic leukemia: Study design and preliminary results

被引：0
作者：
Pui, C. -H. [1 ]
Relling, M. V. [1 ]
Sandlund, J. T. [1 ]
Downing, J. R. [1 ]
Campana, D. [1 ]
Evans, E. [1 ]
机构：
[1] Univ Tennessee, St Jude Childrens Res Hosp, Hlth Sci Ctr, Memphis, TN 38163 USA
来源：
ANNALS OF HEMATOLOGY | 2006年 / 85卷
关键词：
acute lymphoblastic leukemia; cranial irradiation; methotrexate; central-nervous-system leukemia; risk assessment; pharmacogenetics;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：88 / 91
页数：4
相关论文
共 33 条
[1]   Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II [J].
Aricò, M ;
Valsecchi, MG ;
Conter, V ;
Rizzari, C ;
Pession, A ;
Messina, C ;
Barisone, E ;
Poggi, V ;
De Rossi, G ;
Locatelli, F ;
Micalizzi, MC ;
Basso, G ;
Masera, G .
BLOOD, 2002, 100 (02) :420-426
[2]   Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL [J].
Bader, P ;
Hancock, J ;
Kreyenberg, H ;
Goulden, NJ ;
Niethammer, D ;
Oakhill, A ;
Steward, CG ;
Handgretinger, R ;
Beck, JF ;
Klingebiel, T .
LEUKEMIA, 2002, 16 (09) :1668-1672
[3]   Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia:: Significance of low leukocyte counts with blasts or traumatic lumbar puncture [J].
Bürger, B ;
Zimmermann, M ;
Mann, G ;
Kühl, J ;
Löning, L ;
Reihm, H ;
Reiter, A ;
Schrappe, M .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :184-188
[4]   Determination of minimal residual disease in leukaemia patients [J].
Campana, D .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (06) :823-838
[5]   Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes [J].
Cheng, Q ;
Yang, WJ ;
Raimondi, SC ;
Pui, CH ;
Relling, MV ;
Evans, WE .
NATURE GENETICS, 2005, 37 (08) :878-882
[6]   Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells [J].
Cheok, MH ;
Yang, WL ;
Pui, CH ;
Downing, JR ;
Cheng, C ;
Naeve, CW ;
Relling, MV ;
Evans, WE .
NATURE GENETICS, 2003, 34 (01) :85-90
[7]   Moving towards individualized medicine with pharmacogenomics [J].
Evans, WE ;
Relling, MV .
NATURE, 2004, 429 (6990) :464-468
[8]   Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia [J].
Evans, WE ;
Relling, MV ;
Rodman, JH ;
Crom, WR ;
Boyett, JM ;
Pui, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (08) :499-505
[9]  
Gajjar A, 2000, BLOOD, V96, P3381
[10]   Intrinsic and acquired resistance to methotrexate in acute leukemia [J].
Gorlick, R ;
Goker, E ;
Trippett, T ;
Waltham, M ;
Banerjee, D ;
Bertino, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1041-1048
1234